companydata.dkcompanydata.dk

Allarity Therapeutics A/S: Financial statements 2014

CVR: 28106351

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

Allarity Therapeutics A/S (CVR 28106351) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 4,315,459 and a net result of DKK -5,347,074 compared with DKK -3,539,007 the year before. That is an increase of 6.6% compared with the year before. The profit margin was -123.9%. Equity in the 2014 report amounted to DKK 22,219,208. The solvency ratio was 91%.

Revenue
DKK 4,315,459
Gross Profit
DKK -4,405,010
Profit/Loss
DKK -5,347,074
Equity
DKK 22,219,208
Total Assets
DKK 24,412,603

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20144.3M-4.4M-5.3M22.2M-
20134M184K-3.5M10.4M-
20123.9M566K-2.8M4.5M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

Allarity Therapeutics A/S: The 2013 annual report is outApr 30, 2014

Allarity Therapeutics A/S has published its annual report for 2013. Revenue came to DKK 4,049,607, and the net result was DKK -3,539,007.

Gunnar Magnus Severus Modée Persson joins the board of Allarity Therapeutics A/SApr 24, 2014

As of April 24, 2014, Gunnar Magnus Severus Modée Persson has joined the board of directors of Allarity Therapeutics A/S.

About Allarity Therapeutics A/S

Allarity Therapeutics A/S was a Danish company of the type Aktieselskab based in Hørsholm, founded in 2004. The company has been dissolved on 16 October 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ONCOLOGY VENTURE A/S and MEDICAL PROGNOSIS INSTITUTE A/S. The company has 6 employees (2021). In 2024, the company reported a gross profit of DKK -81,000 and a net result of DKK -83,000 compared with DKK -406,000 the year before. Equity in the 2024 report amounted to DKK 0.

Source: annual report 2024, Danish Business Authority